Home/Filings/4/0001048477-24-000048
4//SEC Filing

Davis George Eric 4

Accession 0001048477-24-000048

CIK 0001048477other

Filed

Mar 18, 8:00 PM ET

Accepted

Mar 19, 8:53 PM ET

Size

8.2 KB

Accession

0001048477-24-000048

Insider Transaction Report

Form 4
Period: 2024-03-15
Davis George Eric
VP, General Counsel
Transactions
  • Tax Payment

    Common Stock

    2024-03-15$83.87/sh21,699$1,819,89580,458 total
  • Award

    Common Stock

    2024-03-15+10,260102,157 total
  • Award

    Stock Option (Right to Buy Common Stock)

    2024-03-15+22,99022,990 total
    Exercise: $83.87From: 2025-03-15Exp: 2034-03-14Common Stock (22,990 underlying)
Footnotes (2)
  • [F1]Restricted stock units granted March 15, 2024. Price not applicable.
  • [F2]Option grant vests 12/48th on March 15, 2025 and 1/48th on the 15th day of each month thereafter.

Issuer

BIOMARIN PHARMACEUTICAL INC

CIK 0001048477

Entity typeother

Related Parties

1
  • filerCIK 0001380710

Filing Metadata

Form type
4
Filed
Mar 18, 8:00 PM ET
Accepted
Mar 19, 8:53 PM ET
Size
8.2 KB